MedTrace Logo

Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients

NCT02725099 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-01-10

No results posted yet for this study

Summary

To examine chewing versus traditional oral administration of ticagrelor in ST-elevation Myocardial Infarction (STEMI) patients on platelet reactivity.

Conditions

  • Acute Coronary Syndromes
  • ST Elevation Myocardial Infarction

Interventions

DRUG

Chewing Ticagrelor

180 mg Chewing Ticagrelor

DRUG

Oral Ticagrelor

180 mg oral Ticagrelor

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725099 on ClinicalTrials.gov